Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: Comparison with amphetamine

Neuroscience

Volumn 87, Issue 4, 1998, Pages 905-911

  Engber, T M ^a   Dennis, S A ^a   Jones, B E ^a   Miller, M S ^a   Contreras, P C ^a  

^a CEPHALON INC   (United States)

Author keywords

2 deoxyglucose; Autoradiography; Cerebral metabolism; Narcolepsy; Sleep

Indexed keywords

CARBOXYMETHYLCELLULOSE; CENTRAL STIMULANT AGENT; DEOXYGLUCOSE; DEXAMPHETAMINE; GLUCOSE; MODAFINIL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; FRONTAL CORTEX; GLUCOSE UTILIZATION; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PONS RETICULAR FORMATION; PRIORITY JOURNAL; RAT; THALAMUS NUCLEUS; VENTRAL TEGMENTUM; WAKEFULNESS;

AMYGDALA; ANIMALS; BENZHYDRYL COMPOUNDS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DEOXYGLUCOSE; DEXTROAMPHETAMINE; ENERGY METABOLISM; GLUCOSE; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; WAKEFULNESS;

EID: 0032544057     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00015-3     Document Type: Article

References (30)

1. Bastuji H., Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog. Neuropsychopharmac. biol. Psychiat. 12:1988;695-700.
2. Boivin D. B., Montplaisir J., Petit D., Lambert C., Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin. Neuropharmac. 16:1993;46-53.
3. 14C]deoxyglucose in the rat. Brain Res. 261:1983;213-229.
4. Chrobak J. J., Buzsaki G. Selective activation of deep layer (V-VI) retrohippocampal cortical neurons during hippocampal sharp waves in the behaving rat. J. Neurosci. 14:1994;6160-6170.
5. DeSereville J. E., Boer C., Rambert F. A., Duteil J. Lack of presynaptic dopaminergic involvement in modafinil activity in anesthetized mice: in vivo voltammetry studies. Neuropharmacology. 33:1994;755-761.
6. Ferraro L., Tanganelli S., O'Connor W. T., Antonelli T., Rambert F., Fuxe K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmac. 306:1996;33-39.
7. 3 receptor. Neurosci. Lett. 220:1996;5-8.
8. Ferraro L., Antonelli T., O'Connor W. T., Tanganelli S., Rambert F., Fuxe K. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. NeuroReport. 8:1997;2883-2887.
9. Hoffman B. B. and Lefkowitz R. J. (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In The Pharmacological Basis of Therapeutics (eds Hardman J. G., Limbird L. E., Molinoff P. B., Ruddon R. W. and Gilman A. G.), pp. 199-248. McGraw-Hill, New York.
10. Hopkins D. A., Holstege G. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat. Expl Brain Res. 32:1978;529-547.
11. Jones B. E. (1995) Reticular formation: cytoarchitecture, transmitters, and projections. In The Rat Nervous System (ed. Paxinos G.), pp. 155-171. Academic, San Diego, CA.
12. Kadekaro M., Crane A. M., Sokoloff L. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc. natn. Acad. Sci. U.S.A. 82:1985;6010-6013.
13. Lagarde D., Milhaud C. Electroencephalographic effects of modafinil, an alpha-1 adrenergic psychostimulant, on the sleep of rhesus monkeys. Sleep. 13:1990;441-448.
14. Lin J. S., Roussel B., Akaoka H., Fort P., Debilly G., Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res. 591:1992;319-326.
15. Lin J. S., Hou Y., Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc. natn. Acad. Sci. U.S.A. 93:1996;14128-14133.
16. Lin J. S., Hou Y., Sakai K., Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci. 16:1996;1523-1537.
17. Mata M., Fink D. J., Gainer H., Smith C. B., Davidsen L., Savaki H., Schwartz W. J., Sokoloff L. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J. Neurochem. 34:1980;213-215.
18. Mignot E., Nishino S., Guilleminault C., Dement W. C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep. 17:1994;436-437.
19. Mitchell I. J., Crossman A. R. In defence of optical density ratios in 2-deoxyglucose autoradiography. Brain Res. 298:1984;191-192.
20. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, Orlando, FL.
21. Porrino L. J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res. 307:1984;311-320.
22. Sanford L. D., Tejani-Butt S. M., Ross R. J., Morrison A. R. Amygdaloid control of alerting and behavioral arousal in rats: involvement of serotonergic mechanisms. Archs ital. Biol. 134:1995;81-99.
23. Sharp F. R., Kilduff T. S., Bzorgchami S., Heller H. C., Allen F. The relationship of local cerebral glucose utilization to optical density ratios. Brain Res. 263:1983;97-103.
24. Shelton J., Nishino S., Vaught J., Dement W. C., Mignot E. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Sleep. 18:1995;817-826.
25. 14C]-2-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;879-916.
26. Tanganelli S., Fuxe K., Ferraro L., Janson A. M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea pig. Naunyn-Schmiedeberg's Arch. Pharmac. 345:1992;461-465.
27. Touret M., Sallanon-Moulin M., Jouvet M. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci. Lett. 189:1995;43-46.
28. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6- hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
29. Vertes R. P., Crane A. M., Colom L. V., Bland B. H. Ascending projections of the posterior nucleus of the hypothalamus: PHA-L analysis in the rat. J. comp. Neurol. 359:1995;90-116.
30. Wechsler L. R., Savaki H. E., Sokoloff L. Effects of D- and L-amphetamine on local cerebral glucose utilization in the conscious rat. J. Neurochem. 32:1979;15-22.